Attached files
| file | filename |
|---|---|
| 10-K - 10-K - HALOZYME THERAPEUTICS, INC. | halo2017-10k.htm |
| EX-31.1 - EXHIBIT 31.1 - HALOZYME THERAPEUTICS, INC. | ex31110k2017.htm |
| EX-10.34 - EXHIBIT 10.34 - HALOZYME THERAPEUTICS, INC. | ex103410k2017loanamendment.htm |
| EX-32 - EXHIBIT 32 - HALOZYME THERAPEUTICS, INC. | ex3210k2017.htm |
| EX-23.1 - EXHIBIT 23.1 - HALOZYME THERAPEUTICS, INC. | ex231auditorconsent.htm |
| EX-31.2 - EXHIBIT 31.2 - HALOZYME THERAPEUTICS, INC. | ex31210k2017.htm |
EXHIBIT 21.1
SUBSIDIARIES OF HALOZYME THERAPEUTICS, INC.
Name of Subsidiary | State or Jurisdiction of Incorporation or Organization | Percent Owned | ||
Halozyme, Inc. | California | 100% | ||
Halozyme Holdings Ltd., a wholly owned subsidiary of Halozyme Switzerland Holdings GmbH | Bermuda | 100% | ||
Halozyme Royalty LLC, a wholly owned subsidiary of Halozyme, Inc. | Delaware | 100% | ||
Halozyme Switzerland GmbH, a wholly owned subsidiary of Halozyme Switzerland Holdings GmbH | Switzerland | 100% | ||
Halozyme Switzerland Holdings GmbH, a wholly owned subsidiary of Halozyme, Inc. | Switzerland | 100% | ||